Work

Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study

Year: 2022

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet. Gastroenterology & hepatology

DOI: 10.1016/s2468-1253(22)00347-8

Authors: Rohit Loomba, Eric J Lawitz, Juan Pablo Frias, Grisell Ortiz-Lasanta, Lars Johansson, Bridgette Boggess Franey, Linda Morrow, Moti Rosenstock, Cynthia L Hartsfield, Chao-Yin Chen, Leo Tseng, R Will Charlton, Hank Mansbach, Maya Margalit

Institutions: University of California San Diego, The University of Texas at San Antonio Health Science Center, Texas Liver Institute, Velocity Clinical Research (United States), Antaros Medical (Sweden), 89bio (United States)

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4311426185

FWCI: 11.6

Cites: 34

Cited by: 108

Related to: 10